EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Helius Medical Technologies's Enterprise Value is $0.15 Mil.
Helius Medical Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-10.24 Mil. Therefore, Helius Medical Technologies's EV-to-FCF for today is -0.01.
The historical rank and industry rank for Helius Medical Technologies's EV-to-FCF or its related term are showing as below:
HSDT'
s EV-to-FCF Range Over the Past 10 Years
Min: -9.74 Med: -0.59 Max: 0.8
Current: -0.01
During the past 10 years, the highest EV-to-FCF of Helius Medical Technologies was 0.80. The lowest was -9.74. And the median was -0.59.
HSDT's EV-to-FCF is ranked better than 94.49% of 363
companies
in the Medical Devices & Instruments industry
Industry Median: 28.4
vs HSDT: -0.01
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Helius Medical Technologies's EV-to-FCF
For the Medical Devices subindustry, Helius Medical Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Helius Medical Technologies's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Helius Medical Technologies's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Helius Medical Technologies's EV-to-FCF falls into.
Helius Medical Technologies's current Enterprise Value is $0.15 Mil.
Helius Medical Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Helius Medical Technologies (NAS:HSDT) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Helius Medical Technologies's PE Ratio for today is calculated as:
Helius Medical Technologies's share price for today is $1.48.
Helius Medical Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.530.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Helius Medical Technologies EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Helius Medical Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Helius Medical Technologies (Helius Medical Technologies) Business Description
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HSDT has been successfully added to your 